Business
Johnson & Johnson gears up for collaboration on COVID vaccine supply – Sydney Morning Herald
The pharmaceutical giant is progressing development of its COVID vaccine, potentially giving Australia another option to import.
Pharmaceutical giant Johnson & Johnson is rapidly scaling up its manufacturing capabilities as it progresses development of its COVID vaccine and says it will be looking to work with governments to discuss fast-tracking supply if successful.
The vaccine hopeful is yet another option Australia will most likely have to negotiate to import if it wants supply, with the $US390 billion ($544 billion) biotech firm looking to the US and Europe for trials and broader manufacturing.
From AstraZeneca…
-
Noosa News20 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News21 hours agoDid you lose your ring?
-
Business24 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Business19 hours agoHow to turn $500 a month into $500,000 with ASX shares